The <scp>ERK5</scp> pathway in <scp>BRAFV600E</scp> melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib
Anil K. Mondru(University of Liverpool), Michael Cross(Comprehensive Cancer Center Mainfranken)
Cited by 9
Related Papers
Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies
|Stem Cells Translational Medicine|2015|136
RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells
|Angiogenesis|2017|62